Aspirin Improves Nonalcoholic Fatty Liver Disease and Atherosclerosis through Regulation of the PPAR<i>δ</i>‐AMPK‐PGC‐1<i>α</i> Pathway in Dyslipidemic ConditionsYoon-Mi Han, Ji Hoon Jeong|BioMed Research International|2020Cited by 41